McClain’s employer is a clinic and research facility that focuses on
the patient as a whole and the unique biological response of his or her
immune system to ward of disease. Doug McClain, Chief research
Coordinator at his firm, knows all too well the importance of this
individualized approach to immunotherapy and travels around the world
teaching immunotherapy protocol to fellow researchers. This immune
system uses the body's biological defense mechanism to defeat pathogens
such as bacteria or virus, cancers, fungus, and parasites. This approach
to medicine uses the body's immune system to enhance or suppress the
response to pathogens and mutations such as cancer in order to protect
the body from disease. Immunotherapy is a form of treatment that is
beneficial to the host because it offers relief with minimal side
effects.
Since the inception of his firm, the company has
seen a number of great breakthroughs in the research and development of immunotherapy treatment such as biological response modifiers and
immunomodulators that have dramatically changed the course of chronic
illness and degenerative diseases. These treatments bring new life to
the body's own defense mechanisms and allow for the patient to fight
pathogens naturally.
Doug McClain is a strong believer in the work his company does for those who are sick with incurable diseases. His current focus is on diseases such as diabetes and psoriasis, MS and other autoimmune conditions, but he has hopes of helping in the fight against cancer with his work as well. Making breakthroughs in medicine and treatment methods is one way to work toward finding a cure. McClain is hopeful for the advancement of immunotherapy and what these techniques have to offer patients in the near future.
Since the inception of his firm, the company has
seen a number of great breakthroughs in the research and development of immunotherapy treatment such as biological response modifiers and
immunomodulators that have dramatically changed the course of chronic
illness and degenerative diseases. These treatments bring new life to
the body's own defense mechanisms and allow for the patient to fight
pathogens naturally.Doug McClain is a strong believer in the work his company does for those who are sick with incurable diseases. His current focus is on diseases such as diabetes and psoriasis, MS and other autoimmune conditions, but he has hopes of helping in the fight against cancer with his work as well. Making breakthroughs in medicine and treatment methods is one way to work toward finding a cure. McClain is hopeful for the advancement of immunotherapy and what these techniques have to offer patients in the near future.
